Literature DB >> 27075845

Rapid Detection of Genomic Mutations in gyrA and parC Genes of Escherichia coli by Multiplex Allele Specific Polymerase Chain Reaction.

Sukanlayanee Onseedaeng1, Panan Ratthawongjirakul2.   

Abstract

BACKGROUND: Fluoroquinolone (FR) resistant Escherichia coli infection has become a global problem. The FR resistance usually occurs mainly due to specific point of mutations within the quinolone resistance-determining regions (QRDRs) at the gyrA codon of Ser83 and Asp87 and the parC codon of Ser80 and Glu84. Here, we appraised type and frequency of the QRDR mutations in FR-resistant E. coli isolates, and developed multiplex allele specific PCR (MAS-PCR) for the detection of "hot spot" mutations.
METHODS: A total of 111 ciprofloxacin-resistant E. coli from Ramathibodi Hospital in Bangkok, Thailand, were performed Minimum Inhibitory Concentration (MIC) by Etest® and investigated for gyrA and parC genes' mutations by MAS-PCR. Sensitivity and specificity of MAS-PCR were compared to the sequencing method's.
RESULTS: Ninety-nine of 111 (89.19%) E. coli isolates had mutation at least one point in the QRDRs. Six usual amino acid substitutes were reported, including Ser83-Lue, Asp87-Asn, Asp87-Tyr, Ser80-Ile, Glu84-Gly, and Glu84-Val. MAS-PCR detected codons 83 and 87 in gyrA and codons 80 and 84 in parC mutations, yielding 96.97%, 100%, 100%, and 93.33% sensitivity, respectively, and 100%, 100%, 100%, and 98.48% specificity, respectively.
CONCLUSION: MAS-PCR may be used for rapid detection of FR resistance in routine laboratory as well as in epidemiology study.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990gyrAzzm321990; zzm321990parCzzm321990; QRDRs; fluoroquinolones; multiplex allele specific PCR

Mesh:

Substances:

Year:  2016        PMID: 27075845      PMCID: PMC6807184          DOI: 10.1002/jcla.21961

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Detection of parC mutations in Streptococcus pneumoniae by Real-time PCR and Taqman-MGB probes.

Authors:  Rodrigo Alonso; Estibaliz Mateo; Ramón Cisterna
Journal:  J Microbiol Methods       Date:  2006-12-30       Impact factor: 2.363

3.  Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography.

Authors:  Deborah J Eaves; Ernesto Liebana; Martin J Woodward; Laura J V Piddock
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand.

Authors:  Suwatthiya Siriboon; Surapee Tiengrim; Tawatchai Taweemongkongsup; Visanu Thamlikitkul; Methee Chayakulkeeree
Journal:  Urol Int       Date:  2012-01-21       Impact factor: 2.089

5.  Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allele-specific PCR assay targeting embB306 mutations.

Authors:  Igor Mokrousov; Olga Narvskaya; Elena Limeschenko; Tatiana Otten; Boris Vyshnevskiy
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

6.  Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.

Authors:  J Vila; J Ruiz; P Goñi; M T De Anta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 7.  Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

Authors:  Joaquim Ruiz
Journal:  J Antimicrob Chemother       Date:  2003-04-14       Impact factor: 5.790

8.  Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.

Authors:  You Sun Nam; Sun Young Cho; Hee Young Yang; Kyung Sun Park; Ji-Hyun Jang; Yun-Tae Kim; Joo-Won Jeong; Jin-Tae Suh; Hee Joo Lee
Journal:  Int J Antimicrob Agents       Date:  2012-12-20       Impact factor: 5.283

9.  Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli.

Authors:  Yingmei Fu; Wenli Zhang; Hong Wang; Song Zhao; Yang Chen; Fanfei Meng; Ying Zhang; Hui Xu; Xiaobei Chen; Fengmin Zhang
Journal:  BMC Infect Dis       Date:  2013-01-07       Impact factor: 3.090

10.  Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil.

Authors:  Luciene A R Minarini; Ana Lucia C Darini
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more
  4 in total

1.  Evolution of ß-lactams, fluroquinolones and colistin resistance and genetic profiles in Salmonella isolates from pork in northern Italy.

Authors:  Ilaria Carmosino; Silvia Bonardi; Martina Rega; Andrea Luppi; Luca Lamperti; Maria Cristina Ossiprandi; Cristina Bacci
Journal:  Ital J Food Saf       Date:  2022-06-21

2.  Plasmid-mediated fluoroquinolone resistance associated with extra-intestinal Escherichia coli isolates from hospital samples.

Authors:  Shruthi S Shetty; Vijaya Kumar Deekshit; Kadeeja Jazeela; Rajeshwari Vittal; Anusha Rohit; Anirban Chakraborty; Indrani Karunasagar
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

3.  Increasing Prevalence of ESBL-Producing Multidrug Resistance Escherichia coli From Diseased Pets in Beijing, China From 2012 to 2017.

Authors:  Yanyun Chen; Zhihai Liu; Yaru Zhang; Zhenbiao Zhang; Lei Lei; Zhaofei Xia
Journal:  Front Microbiol       Date:  2019-12-10       Impact factor: 5.640

4.  Antimicrobial Susceptibility and Genomic Analysis of Aliarcobacter cibarius and Aliarcobacter thereius, Two Rarely Detected Aliarcobacter Species.

Authors:  Ingrid Hänel; Eva Müller; Belén González Santamarina; Herbert Tomaso; Helmut Hotzel; Anne Busch
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.